Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial

Rapid musculoskeletal ultrasound for painful episodes in adult haemophilia patients

(2013) A. Ceponis et al.   HAEMOPHILIA

Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B

(2013) Jerry S. Powell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Guidelines for the management of hemophilia

(2012) A. Srivastava et al.   HAEMOPHILIA

Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX

(2012) P. W. COLLINS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide

(2011) H. Ostergaard et al.   BLOOD

Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B

(2011) C. Negrier et al.   BLOOD

Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile

(2010) E. SANTAGOSTINO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006)

(2009) M. CHITLUR et al.   HAEMOPHILIA